Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease.

"Declarations Ethics approval and consent to participateThe collection and use of human samples in accordance with the Declaration of Helsinki was approved by the ethics committee of the Karolinska Institutet (2016/658–31/2). In vivo xenograft studies were conducted in accordance with the approved animal ethical permit (11159–2018). Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding Open access funding provided by Karolinska Institute. This work is supported by National Research Foundation of Singapore (NRF-CRP26-2021RS-0001), Core Funds @ A*STAR SIgN, The Swedish Cancer Society (#21 1524 Pj, 20 0989 PjF; CAN 2017/1103), The Cancer Research Funds of Radiumhemmet (#211253, #214083), The Swedish Research Council (2022–00723, 2021–01247), The Swedish Childhood Cancer Foundation (PR2020-0123), and Karolinska Institutet."